Eksempler på brug af
Integrilin
på Engelsk og deres oversættelser til Dansk
{-}
Medicine
Colloquial
Official
Financial
Ecclesiastic
Official/political
Computer
What is INTEGRILIN used for?
Hvad anvendes INTEGRILIN til?
Other information about INTEGRILIN.
Andre oplysninger om INTEGRILIN.
Why has INTEGRILIN been approved?
Hvorfor blev INTEGRILIN godkendt?
What is the risk associated with INTEGRILIN?
Hvilken risiko er der forbundet med INTEGRILIN?
INTEGRILIN is not compatible with furosemide.
INTEGRILIN er ikke forligeligt med furosemid.
How to take INTEGRILIN 4.
Sådan skal du bruge INTEGRILIN 4.
INTEGRILIN 2 mg/ ml, solution for injection.
INTEGRILIN 2 mg/ ml injektionsvæske, opløsning.
How to store INTEGRILIN 6.
Sådan opbevarer du INTEGRILIN 6.
INTEGRILIN is an inhibitor of platelet aggregation.
INTEGRILIN er en pladeaggregationshæmmer.
The full EPAR for INTEGRILIN can be found here.
Den fuldstændige EPAR for INTEGRILIN kan ses her.
INTEGRILIN contains 0.75 mg/ ml of eptifibatide.
INTEGRILIN indeholder 0, 75 mg/ ml eptifibatid.
What benefit has INTEGRILIN shown during the studies?
Hvilke fordele viser undersøgelserne, at der er ved INTEGRILIN?
INTEGRILIN contains the active substance eptifibatide.
INTEGRILIN indeholder det aktive stof eptifibatid.
Only limited experience exists for readministration of INTEGRILIN.
Der er kun begrænsede erfaringer med gentagen anvendelse af INTEGRILIN.
There is no experience with INTEGRILIN and low molecular weight heparins.
Der er ingen erfaringer med INTEGRILIN og lavmolekylære hepariner.
INTEGRILIN is given into the vein by direct injection followed by an infusion drip solution.
INTEGRILIN gives i en vene ved direkte injektion efterfulgt af infusion drop.
They recommended that INTEGRILIN be given marketing authorisation.
Udvalget anbefalede udstedelse af markedsføringstilladelse for INTEGRILIN.
INTEGRILIN is intended for use with acetylsalicylic acid and unfractionated heparin.
INTEGRILIN er beregnet til anvendelse sammen med acetylsalicylsyre og ufraktioneret heparin.
Ml vial, pack of one vial to be used with INTEGRILIN solution for injection.
Ml hætteglas, pakning med et hætteglas anvendes sammen med INTEGRILIN injektionsvæske, opløsning.
Not relevant, as INTEGRILIN is intended for use in hospitalised patients.
Ikke relevant, da INTEGRILIN er beregnet til patienter indlagt på hospital.
If serious bleeding occurs that isnot controllable with pressure, immediately stop the INTEGRILIN infusion and any unfractionated heparin that is given concomitantly.
Hvis der forekommer alvorlig blødning, der ikke kan kontrolleres med tryk,så stop øjeblikkeligt infusionen med INTEGRILIN og eventuel ufraktioneret heparin, der gives samtidig.
Protection of INTEGRILIN solution from light is not necessary during administration.
Det er ikke nødvendigt at beskytte INTEGRILIN- opløsning mod lys under selve indgivelsen.
Data are limited on the use of INTEGRILIN in patients receiving thrombolytic agents.
Data er begrænsede for anvendelse af INTEGRILIN til patienter, der får trombolytiske stoffer.
INTEGRILIN solution for infusion must be used in conjunction with INTEGRILIN solution for injection.
INTEGRILIN infusionsvæske, opløsning skal anvendes i forbindelse med INTEGRILIN injektionsvæske, opløsning.
Pregnancy and breast-feeding The use of INTEGRILIN during pregnancy is recommended only if it is very important for you to have it.
Graviditet og amning Anvendelse af INTEGRILIN under graviditet anbefales kun, hvis det er meget vigtigt for dig at få det.
INTEGRILIN should be given intravenously(into a vein) by a doctor who has experience in the management of heart conditions.
INTEGRILIN må gives intravenøst(i en vene) af en læge, der har erfaring med behandling af hjertetilstande.
Examples of these newer agents include abciximab(Reopro) and eptifibatide(Integrilin); these agents represent a major advance in enhancing the safety and efficacy of percutaneous coronary intervention in selected patients.
Eksempler på disse nyere præparater omfatter abciximab(Reopro) og eptifibatid(Integrilin); disse stoffer udgør et stort fremskridt i styrkelsen af sikkerheden og effekten af perkutan koronar intervention hos udvalgte patienter.
INTEGRILIN did not appear to increase the risk of major and minor bleeding associated with concomitant use of warfarin and dipyridamole.
INTEGRILIN synes ikke at give en øget risiko for større eller mindre blødninger i forbindelse med samtidig brug af warfarin og dipyridamol.
If treatment with INTEGRILIN is repeated, no diminished therapeutic response is expected.
Ved gentagen behandling med INTEGRILIN, er der derfor ingen forventning om formindsket terapeutisk respons.
The main risk of INTEGRILIN is bleeding(in more than one in 10 patients), and this may sometimes be severe.
Den største risiko ved INTEGRILIN er blødning(hos flere end 1 ud af 10 patienter), og dette kan sommetider være alvorligt.
Resultater: 59,
Tid: 0.0418
Sådan bruges "integrilin" i en sætning
New drugs which include Integrilin and Aggrastat (from the Saw Scaled Viper) are synthetically produced disintegrins, which act as anti-blood-clotting agents.
Tcheng, Duke Clinical Research Institute, presented results of the ESPRIT trial (Enhanced Suppression of the Platelet IIb/IIIA Receptor with Integrilin Therapy).
Another 48 patients were randomized in a 3:1, double-blind fashion to receive the highest Integrilin dose from the first phase or placebo.
When enzyme or ECG criteria are available, they take precedence.
= Platelet Glycoprotein IIb/IIIa in Unstable Angina Receptor Suppression Using Integrilin (Eptifibatide) Therapy.
Goodman SG, Fitchett D, Armstrong PW, et al.; for the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) Trial Investigators.
Integrilin was modified by adding a short PEG linker ending in a maleimide moiety that can selectively couple to free cysteine residues in proteins.
Integrilin is also used to prevent blood clotting prior to surgery to expedite the procedure to open the artery and insert objects or surgical tools.
One such peptide, integrilin, was used as a targeting domain to link with FVIII as it has been shown that integrilin can selectively bind to GPIIb/IIIa.
If the an integrilin (eptifibatide) infection is inside the outer ear and is fairly very simple there is no have to have in the direction of trouble.
In the study, patients took either a placebo or Integrilin for up to 72 hours and, after 30 days, were assessed for the effectiveness of the drug.
English
Deutsch
Español
Suomi
Français
Norsk
عربى
Български
বাংলা
Český
Ελληνικά
עִברִית
हिंदी
Hrvatski
Magyar
Bahasa indonesia
Italiano
日本語
Қазақ
한국어
മലയാളം
मराठी
Bahasa malay
Nederlands
Polski
Português
Română
Русский
Slovenský
Slovenski
Српски
Svenska
தமிழ்
తెలుగు
ไทย
Tagalog
Turkce
Українська
اردو
Tiếng việt
中文